medigraphic.com
ISSN 0035-0052 (Print)

2021, Number 4

Next >>

Rev Mex Pediatr 2021; 88 (4)

Vitamin D, obesity and COVID-19 in pediatrics

Zurita-Cruz JN, Pérez-Cervantes SA

Language: Spanish
References: 35
Page: 129-132
PDF size: 196.31 Kb.





REFERENCES

  1. Saggese G, Vierucci F, Boot AM, Czech-Kowalska J, Weber G, Camargo CA Jr. et al. Vitamin D in childhood and adolescence: an expert position statement. Eur J Pediatr. 2015; 174 (5): 565-576.

  2. Chang SW, Lee HC. Vitamin D and health - The missing vitamin in humans. Pediatr Neonatol. 2019; 60 (3): 237-244.

  3. Elizondo-Montemayor L, Ugalde-casas PA, Serrano-González M, Cuello-García CA, Borbolla-Escoboza JR. Serum 25-hydroxyvitamin D concentration, life factors and obesity in Mexican children. Obesity (Silver Spring). 2009; 18 (9): 1805-1811.

  4. Hossein-Nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013; 88 (7): 720-755.

  5. Gröber U, Spitz J, Reichrath J, Kisters K, Holick MF. Vitamin D: update 2013: from rickets prophylaxis to general preventive healthcare. Dermatoendocrinol. 2013; 5 (3): 331-347.

  6. Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013; 88 (7): 720-755.

  7. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266-281.

  8. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. JCEM. 2011; 96: 1911-1930.

  9. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N et al. Vitamin D and chronic diseases. Aging Dis. 2017; 8 (3): 346-353.

  10. Hewison, M. An update on vitamin D and human immunity. Clin Endocrinol (Oxt). 2012; 76 (3): 315-325.

  11. Nogueira-de-almeida CA, Del LA, Ferraz IS, Del IRL, Contini AA, Ued V. COVID-19 and obesity in childhood and adolescence: a clinical review. J Pediatr (Rio J). 2020; 96 (5): 546-558.

  12. Zakharova I, Klimov L, Kuryaninova V, Nikitina I, Malyavskaya S, Dolbnya S et al. Vitamin D insufficiency in overweight and obese children and adolescents. Front Endocrinol (Lausanne). 2019; 10: 103.

  13. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune disease, cancers and cardiovascular disease. Am J Clin Nutr. 2004; 80 (60 Suppl): 678S-688S.

  14. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007; 449 (7161): 419-426.

  15. Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, Sozzani S. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol. 2007; 178 (1): 145-153.

  16. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system. Arch Biochem Biophys. 2000; 374 (2): 334-338.

  17. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998; 392 (6673): 245-252.

  18. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004; 173 (5): 2909-2912.

  19. Laaksi I. Vitamin D and respiratory infection in adults. Proc Nutr Soc. 2012; 71: 90-97.

  20. Herr C, Shaykhiev R, Bals R. The role of cathelicidin and defensins in pulmonary inflammatory diseases. Expert Opin Biol Ther. 2007; 7 (9): 1449-1461.

  21. Agier J, Efenberger M, Brzezinska-Blaszczyk E. Cathelicidin impact on inflammatory cells. Cent Eur J Immunol. 2015; 40 (2): 225-235.

  22. Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J et al. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One. 2011; 6 (10): e25333.

  23. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF et al. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol. 2009; 182 (7): 4289-4295.

  24. Thornton KA, Marin C, Mora-Plazas M, Villamor E. Vitamin D deficiency associated with increased incidence of gastrointestinal and ear infections in school-age children. Pediatr Infect Dis J. 2013; 32 (6): 585-593.

  25. Science M, Maguire JL, Russell ML, Smieja M, Walter SD, Loeb M. Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clin Infect Dis. 2013; 57 (3): 392-397.

  26. Urashima M, Segawa T, Okazaki M, KuriharaM, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza: a in schoolchildren. Am J Clin Nutr. 2010; 91 (5): 1255-1260.

  27. Grant CC, Kaur S,Waymouth E, Mitchell EA, Scragg R, Ekeroma A et al. Reduced primary care respiratory infection visits following pregnancy and infancy vitamin D supplementation: a randomised controlled trial. Acta Paediatr. 2015; 104 (4): 396-404.

  28. Xiao L, Xing C, Yang Z, Xu S, Wang M, Du H et al. Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials. Br J Nutr. 2015; 114 (7): 1026-1034.

  29. Jolliffe DA, Camargo CA Jr, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of aggregate data from randomised controlled trials. MedRxiv [Preprint]. 2020: 2020.07.14.20152728.

  30. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323 (11): 1061-1069.

  31. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395 (10229): 1054-1062.

  32. Ludvigsson JF. Systematic review of COVID-19 in children show milder cases and a better prognosis than adults. Acta Paediatr. 2020; 109 (6): 1088-1095.

  33. Moreno-Noguez M, Rivas-Ruiz R, Roy-García IA, Pacheco-Rosas DO, Moreno-Espinosa S, Flores-Pulido AA. Factores de riesgo asociados con neumonía por SARS-CoV-2 en población pediatrica. Bol Med Hosp Infant Mex. 2021; 78 (4): 251-258.

  34. Shah K, Varna VP, Pandya A, Saxena D. Low vitamin D levels and prognosis in a COVID-19 pediatric population: a systematic review. QJM. 2021; 114 (7): 447-453.

  35. U.S. National Library of Medicine [Internet]. ClinicalTrials.gov. 2021 [29 November 2021]. Available in: https://clinicaltrials.gov/ct2/results?term=vitamin+D&cond=COVID-19+Respiratory+Infection&age_v=&gndr=&type=Intr&rslt=&Search=Apply




2020     |     www.medigraphic.com